Treatment of Nonseminoma: Stage I
Author:
Publisher
Springer London
Link
http://link.springer.com/content/pdf/10.1007/978-1-84800-370-5_10
Reference112 articles.
1. Albers PP, Bender HH, Yilmaz HH, Schoeneich GG, Biersack HHJ, Mueller SSC (1999) Positron emission tomography in the clinical staging of patients with Stage I and II testicular germ cell tumors. Urology 53(4):808–811
2. Albers P, Siener R, Kliesch S, Weissbach L, Krege S, Sparwasser C et al (2003) Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group trial. J Clin Oncol 21(8):1505–1512
3. Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Horwich A, Klepp O, Laguna MP, Pizzocaro G. Eur Urol. 2005 Dec;48(6):885–94. Epub 2005 Jul 18. Review.
4. Albers P, Siener R, Krege S, Schemelz H, Dieckmann K, Heidenreich A et al (2006) One course of adjuvant PEB chemotherapy versus retroperitoneal lymph node dissection in patients with stage I non-seminomatous germ-cell tumors (NSGCT). Results of the German prospective multicenter trial (Association of Urological Oncology[AUO]/German testicular cancer study group [GTCSG] trial 01-94). J Clin Oncol 24:220S
5. Alexandre J, Fizazi K, Mahe C, Culine S, Droz JP, Theodore C et al (2001) Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapse. Eur J Cancer 37(5):576–582
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Management of Clinical Stage I Nonseminomatous Germ Cell Testicular Tumors: A 25-year Single-center Experience;Clinical Genitourinary Cancer;2017-12
2. Management of patients with clinical stage I nonseminomatous germ cell testicular cancer: Active surveillance versus adjuvant chemotherapy – single-centre experience;Neoplasma;2015
3. Retroperitoneal Lymph Node Dissection for the Primary Treatment Recommendation in Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Contrary to European Guidelines;European Urology Supplements;2011-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3